Biomarkers for Early-Stage Breast Cancer: Clinical Utility for Extended Adjuvant Treatment Decisions

J Clin Oncol. 2016 Nov 10;34(32):3941-3942. doi: 10.1200/JCO.2016.67.2949.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Agents, Hormonal*
  • Biomarkers
  • Breast Neoplasms*
  • Chemotherapy, Adjuvant
  • Decision Making
  • Humans
  • Neoplasm Staging

Substances

  • Antineoplastic Agents, Hormonal
  • Biomarkers